Erika Regina Manuli
Overview
Explore the profile of Erika Regina Manuli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramundo M, da Fonseca G, Ten-Caten F, Gerber A, Guimaraes A, Manuli E, et al.
Sci Rep
. 2025 Feb;
15(1):6745.
PMID: 40000671
Chikungunya virus (CHIKV) infection often results in a chronic joint condition known as Post-Chikungunya Chronic Inflammatory Joint Disease (pCHIKV-CIJD). This condition disrupts individuals' daily lives and contributes to increased healthcare...
2.
de Britto-Costa L, de Oliveira V, Razzolini M, Nunes F, de Oliveira Xavier G, Manuli E, et al.
Am J Infect Control
. 2025 Feb;
PMID: 39956434
Background: The Centres for Antimicrobial Optimization Network Brazil aims to implement an antimicrobial stewardship program in Brazilian municipality. This study explores barriers and enablers to its implementation, through understanding the...
3.
Moreira C, Bierrenbach A, Taconeli C, Oliveira-da Silva L, Buss L, Keating S, et al.
Front Parasitol
. 2025 Jan;
2():1235925.
PMID: 39816837
Background: Evaluating the effectiveness of Chagas disease treatment poses challenges due to the lack of biomarkers for disease progression and therapeutic response. In this study, we aimed to assess the...
4.
de Oliveira V, de Britto-Costa L, de Aragao G, Scaccia N, Mamana A, Cortes M, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Sep;
43(12):2323-2333.
PMID: 39320520
Background: Limited information exists on carriage of multidrug-resistant organisms (MDRO) by health workers (HWs) in primary care settings. This study aims to determine the prevalence of MDRO carriage among HWs...
5.
Daude M, Manuli E, Pereira G, Junior A, Souza U, de Araujo G, et al.
Braz J Infect Dis
. 2024 Jul;
28(4):103855.
PMID: 39053887
In Brazil, Dengue, Zika and Chikungunya viruses constitute a major threat to the public health system. Simultaneous circulation of these arboviruses occurs in many regions of the world due to...
6.
de Oliveira T, Oliveira Leite T, Miranda W, Manuli E, Leal F, Sabino E, et al.
Anal Chim Acta
. 2023 Apr;
1257:341167.
PMID: 37062564
The world is in a long pandemic period caused by the SARS-CoV-2 virus and massive diagnostic tests to assist efforts to control the spread of the disease and also to...
7.
Dos Santos Lazari C, Ramundo M, Ten-Caten F, Bressan C, de Filippis A, Manuli E, et al.
PLoS Negl Trop Dis
. 2023 Jan;
17(1):e0011037.
PMID: 36608155
Background: Chikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25-40% individuals and, though most of...
8.
Oliveira B, de Oliveira L, Mendes de Oliveira F, Pereira G, de Souza R, Manuli E, et al.
Rev Inst Med Trop Sao Paulo
. 2022 Oct;
64:e63.
PMID: 36197424
COVID-19 disease is spread worldwide and diagnostic techniques have been studied in order to contain the pandemic. Immunochromatographic (IC) assays are feasible and a low-cost alternative especially in low and...
9.
Ferreira G, Claro I, Grosche V, Candido D, Jose D, Rocha E, et al.
Biologicals
. 2022 Sep;
80:43-52.
PMID: 36175304
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan, China, is the causative agent of the coronavirus disease 2019 (COVID-19). Since its first notification in São Paulo...
10.
Villas-Boas L, Paula A, da Silva Jr A, Paiao H, Tozetto-Mendoza T, Manuli E, et al.
Clinics (Sao Paulo)
. 2022 Jun;
77:100068.
PMID: 35767900
Objectives: The aim of the present study was to evaluate if neutralizing antibody responses induced by infection with the SARS-CoV-2 strain that was dominant at the beginning of the pandemic...